Ocimum Biosolutions | GenomeWeb

Ocimum Biosolutions

The company is also planning a new round of financing, and, with consent, banking its samples with the long-term goal of establishing an Indian biorepository.

NEW YORK (GenomeWeb News) – Transgenomic today said that it has signed an agreement to acquire the biorepository assets of Gene Logic for $250,000 in cash.

NEW YORK (GenomeWeb News) – Life Technologies this week said that it will invest $20 million in expanding its cell culture facility in Inchinnan, Scotland.

Ocimum Biosolutions has rescheduled a planned auction to sell the assets of its genomic services and database subsidiary Gene Logic to accommodate newly identified potential buyers, the company said this week.

Ocimum Biosolutions is seeking a buyer for the assets of genomic services and database subsidiary Gene Logic.
Gene Logic, based in Gaithersburg, Md., is the US subsidiary of Hyderabad, India-based Ocimum. It filed for Chapter 11 in mid-October.

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.
By a GenomeWeb staff reporter

Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.

Biosearch has denied all allegations set forth by Life Technologies in a previously filed patent-infringement lawsuit revolving around the use of fluorescence-quenched oligonucleotide probes in PCR, diagnostics, and other DNA analysis applications.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.